³Ô¹Ï±¬ÁÏ

?? ??

??

Korea

North America

Europe

EN | DE | ES | FR | IT

°ä³ó¾±²Ô²¹&²Ô²ú²õ±è;Öйú

´³²¹±è²¹²Ô&²Ô²ú²õ±è;ÈÕ±¾

APAC

Latin America

PORTUGUESE | SPANISH

?? ??

?? ??

³Ô¹Ï±¬ÁÏ_Logo
??
Clinical
Regulatory
Safety
Quality
Medical
Commercial
Data
Vault AI
Falcon Agentic Labor
Industries
Demo Center

VEEVA Development Cloud

³Ô¹Ï±¬ÁÏ Clinical Platform

Clinical Operations

³Ô¹Ï±¬ÁÏ eTMF

?? ?? ?? ??

³Ô¹Ï±¬ÁÏ CTMS

?? ???? ??? ????? ??

³Ô¹Ï±¬ÁÏ Payments

?? ?? ??? ? ??? ?? ??

³Ô¹Ï±¬ÁÏ Study Startup

???? ???? ???? ???

³Ô¹Ï±¬ÁÏ RTSM

??? ?? ? ??? ?? ??

³Ô¹Ï±¬ÁÏ Site Connect

?? ?? ??? ???

³Ô¹Ï±¬ÁÏ Study Training

?? ??? ??? ? ???

³Ô¹Ï±¬ÁÏ Disclosures

?? ?? ?????? ???

³Ô¹Ï±¬ÁÏ OpenData Clinical

???? ???? ?? ??? ??

Clinical Data

³Ô¹Ï±¬ÁÏ EDC

??? ???? ?? ? ??

³Ô¹Ï±¬ÁÏ DQS

?? ??? ?? ? ??

³Ô¹Ï±¬ÁÏ eCOA

?? ??? ??

³Ô¹Ï±¬ÁÏ Vault Platform ??? ????
Patient Solution? ?? ????

VEEVA Development Cloud

³Ô¹Ï±¬ÁÏ RIM

³Ô¹Ï±¬ÁÏ Registrations

??? ?? ??

³Ô¹Ï±¬ÁÏ Submissions

??? ?? ? ??

³Ô¹Ï±¬ÁÏ Submissions Publishing

?? ??? ??

³Ô¹Ï±¬ÁÏ Submissions Archive

??? ??? ?? ??

³Ô¹Ï±¬ÁÏ Vault Platform ??? ????
³Ô¹Ï±¬ÁÏ Connections Hub

VEEVA Development Cloud

³Ô¹Ï±¬ÁÏ Safety Suite

³Ô¹Ï±¬ÁÏ Safety

???? ??

³Ô¹Ï±¬ÁÏ SafetyDocs

???? ??? ??

³Ô¹Ï±¬ÁÏ Safety Workbench

?? ? ?? ???

³Ô¹Ï±¬ÁÏ Safety Signal

?? ?? ? ??

³Ô¹Ï±¬ÁÏ Vault Platform ??? ????
³Ô¹Ï±¬ÁÏ Connections Hub

VEEVA QUALITY CLOUD

Quality Assurance

³Ô¹Ï±¬ÁÏ QMS

?? ?? ????? ? ??? ??

³Ô¹Ï±¬ÁÏ QualityDocs

GxP ??? ??

³Ô¹Ï±¬ÁÏ Validation Management

?? ?? ????? ?? ? ??

³Ô¹Ï±¬ÁÏ Batch Release

?? ????? ??? ??? ??

³Ô¹Ï±¬ÁÏ Product Surveillance

????? ?? ? ?? ?? ???

³Ô¹Ï±¬ÁÏ Station Manager

??? ?? ?? ??? ?? ??

Training

³Ô¹Ï±¬ÁÏ Training

?? ?? ??? ? ?????? ??

Quality Control

³Ô¹Ï±¬ÁÏ LIMS

??? ?? ??? ?? QC ??? ???

Health and Safety

³Ô¹Ï±¬ÁÏ EHS

??, ?? ? ?? ???? ??

CRO? ?? ³Ô¹Ï±¬ÁÏ ??? ????
³Ô¹Ï±¬ÁÏ Vault Platform ??? ????
³Ô¹Ï±¬ÁÏ Connections Hub

VEEVA MEDICAL SUITE

Operations

³Ô¹Ï±¬ÁÏ Publications

?? ??? ??, ?? ? ??

³Ô¹Ï±¬ÁÏ MedComms

?? ??? ??? ? ??

³Ô¹Ï±¬ÁÏ MedInquiry

?? ?? ?? ? ?? ???

Insights

Veev Medical Insights

???? ???? ????? ?? ???

Engagement

Medical CRM

??? ??? ?? ??

³Ô¹Ï±¬ÁÏ Link Key People

KOL ? KOL ???? ?? ?? ??? ??

³Ô¹Ï±¬ÁÏ Link Workflow

KOL ?????? ????? ??

??? ?? ????
??? ??????? ???
³Ô¹Ï±¬ÁÏ Vault Platform ??? ????
³Ô¹Ï±¬ÁÏ Connections Hub

VEEVA COMMERCIAL SOLUTIONS

Commercial Evidence?

?? ? ??? ????? ?? ??? ????? ??

Applications

CRM Suite

??? ??? ???? ??? ??????

Campaign Manager

??? ? ??? ???

Events Management

??, ??? ? ????? ???

Align

??, ?? ? ?????? ?? ??

Patient CRM

?? ?? ? ??????

Content

??? ??? ?? ??? ?? ?? ???

Marketing Analytics

??? ??, ??? ? ????

Data Science and Analytics Platform

??? ??? ???? ???? ?? ???

Network MDM

??? ??? ?? ???

Data

Global Reference Data

??? HCP ? HCO ???

Global HCP Data

HCP ??? ???

Global Deep Data

KOL ??? ? ?? ???? ???

U.S. Performance Data

?? ??? ?? ?? ? ?? ???

Services

Business Consulting

?? ?? ???


??? ???

Agentic Commercial ??
???? ??? ???
AI ?? MLR ??
 
?? ???? ??
DTC ??
???? ?? ?? ??

VEEVA DATA CLOUD

Global Reference Data

³Ô¹Ï±¬ÁÏ OpenData Commercial

??? HCP ? HCO ???

³Ô¹Ï±¬ÁÏ OpenData Clinical

??? ???? ???? ??? ???

Global HCP Data

³Ô¹Ï±¬ÁÏ HCP Access

HCP ??? ???

Global Deep Data

³Ô¹Ï±¬ÁÏ Link Key People

KOL?? ?? ?? ???

³Ô¹Ï±¬ÁÏ Link Key Accounts

?? ????? ?? ?? ???

U.S. Performance Data

³Ô¹Ï±¬ÁÏ Compass Patient

??? ?? ???

³Ô¹Ï±¬ÁÏ Compass Prescriber

HCP, HCP, HCO, ZIP ?? ???

³Ô¹Ï±¬ÁÏ Compass National

? ? ??? ?? ???

Services

³Ô¹Ï±¬ÁÏ Analytics

?? ?? ???


??? ???

?????? & ???

FOR VAULT PLATFORM
& VEEVA APPLICATIONS

Vault AI

Agentic AI

Vault ???? ??

AI Agents

??? ??? ????? ???? ?????

³Ô¹Ï±¬ÁÏ Vault Platform ??? ????

????? & ????? ??? ??
???? ???

³Ô¹Ï±¬ÁÏ Falcon Agentic Labor

Falcon Clinical

?? ??, ?? ?? ? ??? ?? ???

Falcon Regulatory

AI ?? ??? ?? ? ???? ?? ???

Falcon Safety

???? ??? ?? ? ?? ???

Vault AI ????? ??? ???? ??? ?? ????

Industries

Pharma and Biotech

R&D, ??? ??? ??? ???

Consumer Health

?????? ?????? ???

Animal Health

?? ??? ?? ??? ??????

MedTech

??? ? ??? ??? ???

Demo Center

Clinical Operations

Clinical Data

Regulatory

Safety

Development Cloud

Quality

Commercial

Medical

Data

???

Services

Business Consulting

Partners

Services Partners
Content Partners
CRO Partners
Product Partners
Data Partners
??
???
???
³Ô¹Ï±¬ÁÏ ??

About ³Ô¹Ï±¬ÁÏ

Leadership
Public Benefit Corporation
Corporate Citizenship
Partners
Trust

Contact Us

Generation ³Ô¹Ï±¬ÁÏ

News

Announcements
Press Coverage 
³Ô¹Ï±¬ÁÏ Blog
  • Home
  • Contact
  • ??
    • Clinical Solutions
      • VEEVA Development Cloud
      • ³Ô¹Ï±¬ÁÏ Clinical Platform
      • Clinical Operations
      • ³Ô¹Ï±¬ÁÏ eTMF
      • ³Ô¹Ï±¬ÁÏ CTMS
      • ³Ô¹Ï±¬ÁÏ Payments
      • ³Ô¹Ï±¬ÁÏ Study Startup
      • ³Ô¹Ï±¬ÁÏ RTSM
      • ³Ô¹Ï±¬ÁÏ Site Connect
      • ³Ô¹Ï±¬ÁÏ Study Training
      • ³Ô¹Ï±¬ÁÏ Disclosures
      • ³Ô¹Ï±¬ÁÏ OpenData Clinical
      • Clinical Data
      • ³Ô¹Ï±¬ÁÏ EDC
      • ³Ô¹Ï±¬ÁÏ DQS
      • ³Ô¹Ï±¬ÁÏ eCOA
      • ³Ô¹Ï±¬ÁÏ Vault Platform
      • Patient Solution
    • Regulatory Solutions
      • VEEVA Development Cloud
      • ³Ô¹Ï±¬ÁÏ RIM
      • ³Ô¹Ï±¬ÁÏ Registrations
      • ³Ô¹Ï±¬ÁÏ Submissions
      • ³Ô¹Ï±¬ÁÏ Submissions Publishing
      • ³Ô¹Ï±¬ÁÏ Submissions Archive
      • ³Ô¹Ï±¬ÁÏ Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Safety Solutions
      • VEEVA Development Cloud
      • ³Ô¹Ï±¬ÁÏ Safety
      • ³Ô¹Ï±¬ÁÏ SafetyDocs
      • ³Ô¹Ï±¬ÁÏ Safety Workbench
      • ³Ô¹Ï±¬ÁÏ Safety Signal
      • ³Ô¹Ï±¬ÁÏ Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Quality Solutions
      • ³Ô¹Ï±¬ÁÏ Quality Cloud
      • Content
      • ³Ô¹Ï±¬ÁÏ QualityDocs
      • Vault Station Manager
      • Training
      • ³Ô¹Ï±¬ÁÏ Training
      • Process
      • ³Ô¹Ï±¬ÁÏ QMS
      • ³Ô¹Ï±¬ÁÏ Batch Release
      • ³Ô¹Ï±¬ÁÏ Validation Management
      • ³Ô¹Ï±¬ÁÏ Product Surveillance
      • Lab
      • ³Ô¹Ï±¬ÁÏ LIMS
      • Health and Safety
      • ³Ô¹Ï±¬ÁÏ EHS
      • CRO? ?? ³Ô¹Ï±¬ÁÏ ??? ????
      • ³Ô¹Ï±¬ÁÏ Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • ³Ô¹Ï±¬ÁÏ Medical Suite
      • Operations
      • ³Ô¹Ï±¬ÁÏ Publications
      • ³Ô¹Ï±¬ÁÏ MedComms
      • ³Ô¹Ï±¬ÁÏ MedInquiry
      • Engagement
      • Medical CRM
      • ³Ô¹Ï±¬ÁÏ Link Key People
      • ³Ô¹Ï±¬ÁÏ Link Workflow
      • Insights
      • ³Ô¹Ï±¬ÁÏ Medical Insights
      • ??? ?? ????
      • ??? ??????? ???
      • ³Ô¹Ï±¬ÁÏ Vault Platform ??? ????
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Commercial Solutions
      • VEEVA COMMERCIAL SOLUTIONS
      • Commercial Evidence?
      • Applications
      • CRM Suite
      • Campaign Manager
      • Events Management
      • Align
      • Patient CRM
      • Content
      • Marketing Analytics
      • Data Science and Analytics Platform
      • Network MDM
      • Data
      • Global Reference Data
      • Global HCP Data
      • Global Deep Data
      • U.S. Performance Data
      • Services
      • Business Consulting
    • Data Solutions
      • VEEVA DATA CLOUD
      • Global Reference Data
      • ³Ô¹Ï±¬ÁÏ OpenData Commercial
      • ³Ô¹Ï±¬ÁÏ OpenData Clinical
      • Global HCP Data
      • ³Ô¹Ï±¬ÁÏ HCP Access
      • Global Deep Data
      • ³Ô¹Ï±¬ÁÏ Link Key People
      • ³Ô¹Ï±¬ÁÏ Link Key Accounts
      • U.S. Performance Data
      • ³Ô¹Ï±¬ÁÏ Compass Patient
      • ³Ô¹Ï±¬ÁÏ Compass Prescriber
      • ³Ô¹Ï±¬ÁÏ Compass National
      • Services
      • ³Ô¹Ï±¬ÁÏ Analytics
    • Vault AI
      • VAULT AI
      • Vault AI
      • Agentic AI
      • AI Agents
    • Research Site
    • Industries
      • INDUSTRIES
      • Pharma and Biotech
      • Consumer Health
      • Animal Health
      • MedTech
  • ???
    • Services Overview
    • Business Consulting
    • ³Ô¹Ï±¬ÁÏ Partners
  • ??
  • ???
  • ???
  • ³Ô¹Ï±¬ÁÏ ??
    • Leadership
    • Public Benefit Corporation
    • Corporate Citizenship
    • Partners
    • Trust
    • Careers
    • Generation ³Ô¹Ï±¬ÁÏ
    • News
    • ³Ô¹Ï±¬ÁÏ Blog
    • Contact Us
    •  
Industry Report

VEEVA PULSE FIELD TRENDS REPORT Q4 2024

PDF ????
??

Trends Improving HCP Engagement and Accelerating
Treatment Adoption

³Ô¹Ï±¬ÁÏ Pulse ???? ???, ????? ??? ?? ???? ??? ?? ??? ??? ??? ? HCP(Healthcare Professional, ?? ???)?? ??? ????, ??? ???? ????, ??? ??? ???? ??? ??????. ??? HCP?? ??? ????? ???? ??? ??? ???? ??? ??? ????.

?? ???? ??(KOL)1? ?? ??? ??, ??? ? ??? ?? ???? ???, 44%? ?? ?? ?? ? ?? ??? ???? ????. ???? ??, ??? ?? ??, ??? ???? ?? ? ?? ??? ??? ???? HCP? ??? ????? ??? ????.

"?? ??? ?? ??? ????, ??? ? ??, ??? ?? ? ?? ??? ? ???? ??? ??? ???. ??? ??? ??? ???? ??? ?????. ?, ?? ? ?? ??? ?? ??? ??, ?? ??? ?? ??? ?? ?? ?? ??? ????."

¡ª Dr. Vital Hevia, ???? ?? ? ?? ?? ???, ROC Clinic and HM Hospitals

?? ? ? ??? ³Ô¹Ï±¬ÁÏ Pulse ????? ??? ?? HCP? ??? ???? ???? ??? ??? ???? ? ??? ???? ??? ??? ????.

Dan Rizzo
VP, Global Head of Business Consulting

1 ³Ô¹Ï±¬ÁÏ Survey of 50 Key Opinion Leaders, September-November 2024.


Pre-launch scientific outreach is accelerating treatment
adoption by 40%

Prioritizing investments in targeted scientific activities with the right experts speeds treatment adoption. A U.S.-based study of oncology drugs showed
that biopharmas who invested more in pre-launch scientific activities saw
40% faster treatment adoption than companies that invested less. Field medical engagement with key opinion leaders prior to launch also improves treatment adoption by 50%.

Where companies make investments matters. In the same study, congress activity had the strongest influence on speed of adoption, outpacing the influence of social media, publications, guidelines, and clinical trials. Medical teams should also focus engagement on digitally savvy, early-career HCPs, who are four times more likely to adopt a new treatment.

Synchronized sales and marketing is
improving prescribing behavior

Close and timely coordination of field engagements and HCP digital advertising ¡ª or synchronization ¡ª increases marketing effectiveness by 23%. But 65% of HCP engagements are not synchronized.

Coordinating sales and marketing touchpoints can close the gap, strengthening HCP engagement, increasing scientific understanding, and improving prescribing behavior. In one case study, a rep call was 30% more likely to result in a prescription if it was followed by digital exposure within 10 days.2 Another showed that HCPs exposed to digital ads within 10 days after a speaker program were 25% more likely to prescribe.2

¡°A person¡¯s capacity to ingest content that is not relevant,
not timely, and not delivered in a way that they want to receive
it is probably something like zero. And our job as marketers is
to figure out how to get as close as possible to relevant, timely, and needed content at the right time.¡±

¡ª Erica Taylor, PhD, Vice President, Chief Marketing Officer, Genentech

Connected engagement across sales, marketing, and medical3

2 Source: U.S. ³Ô¹Ï±¬ÁÏ Crossix case studies and ³Ô¹Ï±¬ÁÏ Pulse data, 2023 and 2024.
3 Simplified representation of the connected engagement model

Timely, relevant engagement is mitigating declining access

HCP access declined from 60% to 45% from 2023 to 2024 in the U.S., marking a return to prepandemic
levels. Access levels vary significantly by specialty ¡ª oncology, internal medicine, and psychiatry are the
most difficult to reach. And HCPs are highly selective, with 50% of accessible HCPs limiting engagement
to three or fewer companies.

Connected sales, marketing, and medical teams are mitigating challenging access by extending
conversations, responding quickly to HCPs¡¯ needs, and improving treatment adoption. This commercial
model requires shared data, connected systems, aligned incentives, and a unified understanding of
the customer.

¡°How do we get a better understanding of our customers and make sure
that our messages and the way we approach people is relevant, meaningful,
and treating them as the unique individuals they are, rather than just saying,
¡®I¡¯m going to use the same five slides.¡¯¡±

¡ª Kieron Scrutton, SVP Medical Affairs Digital & Technology, and Tech Governance Risk
and Compliance, GSK


Connect with ³Ô¹Ï±¬ÁÏ Business Consulting to learn how ³Ô¹Ï±¬ÁÏ Pulse data can improve HCP
engagement for your field team.


Global and Regional Trends

This report highlights global and regional field engagement trends from ³Ô¹Ï±¬ÁÏ Pulse data gathered between October
2023 and December 2024. ³Ô¹Ï±¬ÁÏ Pulse data is sourced from ³Ô¹Ï±¬ÁÏ¡¯s aggregated CRM activity, including field
engagement stats from all instances of ³Ô¹Ï±¬ÁÏ CRM globally. In this report, comparisons in trending charts are year
over year, Q4 2023 to Q4 2024, while non-trending charts contain quarter-over-quarter comparisons, Q3 2024 to Q4
2024.

Global trends*

Figure 1: Channel mix evolution, global

Figure 2: Channel mix, global


Global field team activity
Weekly activity per user by engagement channel

Figure 3: Activity by region, global

Figure 4: Activity by user type, global


Global engagement quality
Consolidation of key quality metrics

Figure 5: Approved email volume, global

Figure 6: Content usage by channel, global

Figure 7: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, global

*This quarter¡¯s global trends report omits data from China.

U.S. market trends

Figure 8: Channel mix evolution, U.S.

Figure 9: Channel mix, U.S.


U.S. field team activity
Weekly activity per user by engagement channel

Figure 10: Activity, U.S.

Figure 11: Activity by user type, U.S.


U.S. engagement quality
Consolidation of key quality metrics

Figure 12: Approved email volume, U.S.

Figure 13: Content usage by channel, U.S.

Figure 14: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, U.S.

Europe market trends

Figure 15: Channel mix evolution, Europe

Figure 16: Channel mix, Europe


Europe field team activity
Weekly activity per user by engagement channel

Figure 17: Activity by country, EU5

Figure 18: Activity by user type, Europe


Europe engagement quality
Consolidation of key quality metrics

Figure 19: Approved email volume, Europe

Figure 20: Content usage by channel, Europe

Figure 21: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, Europe

Asia market trends

Figure 22: Channel mix evolution, Asia

Figure 23: Channel mix, Asia


Asia field team activity
Weekly activity per user by engagement channel

Figure 24: Activity by country, Asia

Figure 25: Activity by user type, Asia


Asia engagement quality
Consolidation of key quality metrics

Figure 26: Approved email volume, Asia

Figure 27: Content usage by channel, Asia

Figure 28: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, Asia

Latin America market trends

Figure 29: Channel mix evolution, Latin America

Figure 30: Channel mix, Latin America


Latin America field team activity
Weekly activity per user by engagement channel

Figure 31: Activity by country, Latin America

Figure 32: Activity by user type, Latin America


Latin America engagement quality
Consolidation of key quality metrics

Figure 33: Approved email volume, Latin America

Figure 34: Content usage by channel, Latin America

Figure 35: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, Latin America


Appendix: Data dictionary

Metric definitions

  • Channel mix evolution over time: Weekly ³Ô¹Ï±¬ÁÏ CRM activity volume broken down by the channel of engagement (in-person, phone, video, email, chat or text)
  • Channel mix: Total ³Ô¹Ï±¬ÁÏ CRM activity volume broken out by engagement channel percentage, calculated using percent change during the specified period
  • Weekly activities per user: The average weekly number of ³Ô¹Ï±¬ÁÏ CRM activities submitted per number of users active in ³Ô¹Ï±¬ÁÏ CRM
  • Approved email volume: The average weekly volume of approved emails sent via ³Ô¹Ï±¬ÁÏ CRM, calculated using percent change during the specified period
  • Email open rate: Percentage of approved emails opened at least once out of all approved emails sent via ³Ô¹Ï±¬ÁÏ CRM
  • Email click rate: Percentage of approved emails clicked at least once out of all approved emails sent via ³Ô¹Ï±¬ÁÏ CRM
  • In-person % CLM usage: Percentage of in-person engagements that leveraged content in ³Ô¹Ï±¬ÁÏ CRM
  • Video % CLM usage: Percentage of video engagements that leveraged content in ³Ô¹Ï±¬ÁÏ CRM
  • ³Ô¹Ï±¬ÁÏ CRM Engage meeting % CLM usage: Percentage of ³Ô¹Ï±¬ÁÏ CRM Engage meetings that leveraged content in ³Ô¹Ï±¬ÁÏ CRM
  • ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration: The average duration of ³Ô¹Ï±¬ÁÏ CRM Engage meetings in minutes

Engagement channel definitions

  • In-person: Submitted calls with a CRM Standard Metrics call channel value of ¡®in-person¡¯
  • Phone: Submitted calls with a CRM Standard Metrics call channel value of ¡®phone¡¯
  • Video: ³Ô¹Ï±¬ÁÏ CRM Engage calls and video calls via other platforms that are then recorded as calls in ³Ô¹Ï±¬ÁÏ CRM with a Standard Metrics call channel value of ¡®video¡¯
  • Email: Approved emails and emails sent via other platforms that are then recorded as calls in ³Ô¹Ï±¬ÁÏ CRM with a Standard Metrics call channel value of ¡®email¡¯
  • Chat or text: Submitted calls with a CRM Standard Metrics call channel value of ¡®chat or text¡¯

User type definitions

  • Sales: Users that have been classified with the ¡®sales¡¯ value in the CRM Standard Metrics user type field
  • Key account manager: Users that have been classified with the ¡®key account manager¡¯ value in the CRM Standard Metrics user type field
  • Medical: Users that have been classified with the ¡®medical¡¯ value in the CRM Standard Metrics user type field

Region definitions

  • Global: All markets globally. This quarter¡¯s global trends report omits data from China.
  • Europe: Albania, Andorra, Armenia, Aruba, Austria, Azerbaijan, Belarus, Belgium, Bermuda, Bosnia and Herzegovina,
    Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, French Polynesia, Georgia, Germany,
    Greece, Greenland, Guadeloupe, Guernsey, Hungary, Ireland, Italy, Jersey, Latvia, Lithuania, Luxembourg, Macedonia,
    Malta, Martinique, Republic of Moldova, Monaco, Montenegro, Netherlands, New Caledonia, Norway, Poland, Portugal,
    Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
  • Asia: Australia, Bangladesh, Bhutan, Brunei Darussalam, Cambodia, Cocos (Keeling) Islands, Indonesia, Japan,
    Kazakhstan, Republic of Korea, Kyrgyzstan, Malaysia, Mongolia, Myanmar, Nauru, Nepal, New Zealand, Philippines,
    Samoa, Singapore, Solomon Islands, Sri Lanka, Taiwan, Tajikistan, Thailand, Turkmenistan, Uzbekistan, Vietnam
  • Latin America: Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia, Brazil, Chile, Colombia, Costa
    Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico,
    Nicaragua, Panama, Paraguay, Peru, Trinidad and Tobago, Uruguay, Venezuela

Methodology

The ³Ô¹Ï±¬ÁÏ Pulse Field Trends Report is a quarterly industry benchmark for global and regional healthcare
professional (HCP) engagement across the life sciences industry. The findings are based on:

  • Approximately 600 million annual global field activities captured in ³Ô¹Ï±¬ÁÏ CRM and ³Ô¹Ï±¬ÁÏ CRM Engage.
  • Marketing effectiveness data from ³Ô¹Ï±¬ÁÏ Crossix. Crossix connects anonymized health data on 300+ million patients to media data to measure the impact of direct-to-consumer and HCP marketing investments in the U.S.
  • Anonymous patient longitudinal claims data from ³Ô¹Ï±¬ÁÏ Compass Patient covering dispensed prescriptions, procedures, and diagnoses from 300+ million patients.
  • 4+ million profiles containing publications, clinical trials, conferences, associations, guidelines, grants, payments, social media, news mentions, and patient mix by disease and drug class from ³Ô¹Ï±¬ÁÏ Link Key People in 85+ countries and all major therapeutic areas.
  • Global reference data of HCPs, healthcare organizations, and affiliations from ³Ô¹Ï±¬ÁÏ OpenData, containing addresses, emails, specialties, demographics, and compliance data (license information and industry identifiers) in 100+ countries.

The ³Ô¹Ï±¬ÁÏ Pulse Field Trends Report delivers insights that inform the industry and help field teams align their
strategy to key market trends for improved commercial success. The global ³Ô¹Ï±¬ÁÏ Business Consulting team also
helps customers inform their strategies using industry benchmarking with ³Ô¹Ï±¬ÁÏ Pulse data.

??? ??

³Ô¹Ï±¬ÁÏ? ??? ?????
?? ??? ???? ???????

???? PDF ????

??? ³Ô¹Ï±¬ÁÏ ?? ???? ??? ????? ??? ??? ?????

footer-logo
Clinical ???
Regulatory ???
Quality ???
Safety ???
Medical ???
Commercial ???
?? ??
???
??
???
???
????
??
??
+82-02-6912-0796
?? ??
³Ô¹Ï±¬ÁÏ Systems Korea
??? ??? ???? 87?, 36
?????? 19?
?? ??? ???
³Ô¹Ï±¬ÁÏ Systems - ??? ?? ?? ??? ?? ?????, AI, ??? ? ??? | © Copyright 2026 ³Ô¹Ï±¬ÁÏ Systems
?? ?? ?? ?? | ??